Copay savings card
DiscontinuedSaxenda Savings Card (NovoCare)
Novo Nordisk Inc. · Saxenda
commercial insurance
mendmedsBeta
Free help paying for Saxenda.
The Saxenda Savings Card (NovoCare) has ended. Below is what we verified about it, plus the closest alternatives we track.
The Saxenda Savings Card (NovoCare) has ended
Novo Nordisk Inc. discontinued the Saxenda Savings Card (NovoCare) on December 31, 2023.
No free-drug PAP for Saxenda and savings-card program now discontinued. Generic liraglutide may be cheaper for uninsured patients.
Same active ingredient, different product: Victoza (liraglutide 1.8 mg, 2 active programs).
Saxenda (liraglutide 3 mg) is a glp-1 receptor agonist (weight management) made by Novo Nordisk. It is commonly prescribed for: Chronic weight management (BMI >=30 or >=27 with comorbidity), Adolescent obesity (12-17 years). Without financial assistance, Saxenda typically costs around $1,350 per month.
All Saxenda programs we know about
This is the program we tracked and the final terms we verified before it ended.
Saxenda assistance, answered plainly
Is there a Saxenda patient assistance program?
Not anymore. Novo Nordisk Inc. ran the Saxenda Savings Card (NovoCare), but it ended on December 31, 2023 and we have not verified an active replacement. The alternatives we track are listed on this page.
Is the Saxenda patient support program the same thing as patient assistance?
Manufacturers like Novo Nordisk use "patient support program" as an umbrella term for nurse lines, insurance navigation, and financial help. The financial help is what we track here. The support phone line is listed on the official program site linked above.